DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
TAK-733 is an investigational drug.
There have been 314 clinical trials for TAK-733. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2018.
The most common disease conditions in clinical trials are Diabetes Mellitus, Hypertension, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Takeda, Millennium Pharmaceuticals, Inc., and National Cancer Institute (NCI).
Recent Clinical Trials for TAK-733
|A Pharmacokinetic and Safety Study of TAK-925 in Participants With Idiopathic Hypersomnia||Millennium Pharmaceuticals, Inc.||Phase 1|
|A Study of TAK-994 in Participants With Narcolepsy Type 1||Takeda||Phase 1|
|Intratumoral Microdosing of TAK-981 in Head and Neck Cancer||Takeda||Early Phase 1|